Advances in radioprotection through the use of combined-agent regimens
Technical Report
·
OSTI ID:5998795
The most effective radioprotective agents exhibit toxicities that can limit their usefulness. It may be possible to use combinations of agents with different radioprotective mechanisms of action at less toxic doses, or to reduce the toxicity of the major protective compound by adding another agent. With regard to the latter possibility, improved radioprotection and reduced lethal toxicity of the phosphorothioate WR-2721 was observed when it was administered in combination with metals (selenium, zinc or copper). The known mechanisms of action of potential radioprotective agents and varying effects of different doses and times of administration in relation to radiation exposure must be considered when using combined-agent regimens. A number of receptor-mediated protectors and other biological compounds, including endotoxin, eicosanoids and cytokines, have at least an additive effect when administered before radiation exposure, whereas some immunomodulators have activity when administered with thiol protectors. Eicosanoids and other bioactive lipids must be administered before radiation, exposure, whereas some immunomodulators have activity when administered either before or after radiation exposure.
- Research Organization:
- Armed Forces Radiobiology Research Inst., Bethesda, MD (USA)
- OSTI ID:
- 5998795
- Report Number(s):
- AD-A-227778/8/XAB; AFRRI-SR--90-24
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radioprotective effect of combinations of WR-2721 and mercaptopropionylglycine on mouse bone marrow chromosomes
Sodium hydrogen-S-(3-amino-3-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection. [/sup 60/Co]
In vivo screening of radioprotectors. Annual summary report, March 1982-March 1983
Journal Article
·
Wed Oct 31 23:00:00 EST 1990
· Radiation Research; (USA)
·
OSTI ID:6167509
Sodium hydrogen-S-(3-amino-3-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection. [/sup 60/Co]
Journal Article
·
Sun Feb 28 23:00:00 EST 1982
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:7065926
In vivo screening of radioprotectors. Annual summary report, March 1982-March 1983
Technical Report
·
Wed Jun 01 00:00:00 EDT 1983
·
OSTI ID:5276109
Related Subjects
560152* -- Radiation Effects on Animals-- Animals
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
COPPER
DRUGS
EFFICIENCY
ELEMENTS
METALS
RADIATION PROTECTION
RADIOPROTECTIVE SUBSTANCES
RADIOSENSITIVITY EFFECTS
SELENIUM
SEMIMETALS
SYNERGISM
TOXICITY
TRANSITION ELEMENTS
ZINC
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
COPPER
DRUGS
EFFICIENCY
ELEMENTS
METALS
RADIATION PROTECTION
RADIOPROTECTIVE SUBSTANCES
RADIOSENSITIVITY EFFECTS
SELENIUM
SEMIMETALS
SYNERGISM
TOXICITY
TRANSITION ELEMENTS
ZINC